← Open Payments lookup

JULIE MORRIS: Open Payments

NPI 1902255573 · TACOMA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,535 in 47 payments from 16 companies in 2025. Trend: 2023 $744 · 2024 $842 · 2025 $1,535

Food & beverage: $1,535
CompanyPaymentsAmount
ABBVIE INC.17$361
Janssen Biotech, Inc.6$279
Salix Pharmaceuticals, a division of Bausch Health US, LLC5$276
Madrigal Pharmaceuticals4$126
Ardelyx, Inc.1$120
Takeda Pharmaceuticals U.S.A., Inc.2$68
Aimmune Therapeutics, Inc.2$56
PFIZER INC.2$51
TerSera Therapeutics LLC1$38
Ipsen Biopharmaceuticals, Inc1$30

Products named: TREMFYA, XIFAXAN, LINZESS, REZDIFFRA, IBSRELA, RINVOQ, ENTYVIO, DUPIXENT.

Industry payments across WA — which companies pay providers there.